Alan S. Brown, M.D.
Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital
Clinical Associate Professor, Loyola University Medical Center
Estimated Time of Talk
This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia.
- Understand the effect of hypertriglyceridemia on CHD risk.
- Review treatment strategies to reduce risk of pancreatitis and CHD events.
- Review appropriate therapies for patients with elevated triglycerides.
Conflicts of Interest
Speaker- Amgen, Regeneron, Sanofi, Advisory Board- Amarin, Kastle, Kowa, Pfizer, Sanofi